Denmark Launches Major Insulin Pen Production Line in Iran

Barakat Pharmaceutical Industrial Town in Iran’s Alborz Province has become the new home to Novo Nordisk’s first Flexpen—a prefilled disposable device for the delivery of long-acting insulin products—production line in the Eastern Mediterranean and Middle East region. 
This is the company’s eighth insulin pen plant in the world. 
“Operated by Novo Nordisk Pars, the subsidiary of the Danish pharmaceutical giant, the plant will meet 30% of insulin pen requirement in Iran in its early stages of production,” says Kianoush Jahanpour, an official with the Health Ministry.
“After the expansion, the company will be in a position to increase its reach to diabetic patients in other countries in the region and North Africa.”